Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.
Polyelectrolyte microcapsules (MCs) are potent protein delivery vehicles which can be tailored with ligands to stimulate maturation of dendritic cells (DCs). We investigated the immune stimulatory capacity of monocyte-derived DC (Mo-DC) loaded with these MCs, containing p24 antigen from human immunodeficiency virus type 1 (HIV-1) alone [p24-containing MC (MCp24)] or with the Toll-like receptor ligand 3 (TLR3) ligand poly I:C (MCp24pIC) as a maturation factor. MO-DC, loaded with MCp24pIC, upregulated CCR7, CD80, CD83, and CD86 and produced high amounts of interleukin-12 (IL-12) cytokine, to a similar extent as MCp24 in the presence of an optimized cytokine cocktail. MO-DC from HIV-infected patients under highly active antiretroviral therapy (HAART) exposed to MCp24 together with cytokine cocktail or to MCp24pIC expanded autologous p24-specific CD4(+) and CD8(+) T-cell responses as measured by interferon-gamma (IFN-gamma) and IL-2 cytokine production and secretion. In vivo relevance was shown by immunizing C57BL/6 mice with MCp24pIC, which induced both humoral and cellular p24-specific immune responses. Together these data provide a proof of principle that both antigen and DC maturation signal can be delivered as a complex with polyelectrolyte capsules to stimulate virus-specific T cells both in vitro and in vivo. Polyelectrolyte MCs could be useful for in vivo immunization in HIV-1 and other infections.
De Haes
Winni
W
Institute of Tropical Medicine of Antwerp, Department of Microbiology, Unit Virology, Antwerp, Belgium. wdehaes@itg.be
De Koker
Stefaan
S
Pollard
Charlotte
C
Atkinson
Derek
D
Vlieghe
Erika
E
Hoste
Jessy
J
Rejman
Joanna
J
De Smedt
Stefaan
S
Grooten
Johan
J
Vanham
Guido
G
Van Gulck
Ellen
E
D000818:Animals; D003713:Dendritic Cells / Q000276:immunology*; D004337:Drug Carriers / Q000737:chemistry*; D005260:Female; D016655:HIV Core Protein p24 / Q000737:chemistry / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D056724:Immunity, Humoral / Q000276:immunology; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008856:Microscopy, Fluorescence; D011070:Poly I-C / Q000737:chemistry / Q000276:immunology*; D011108:Polymers / Q000737:chemistry*
D004337:Drug Carriers; D016655:HIV Core Protein p24; D007376:Interleukin-2; D011108:Polymers; D018664:Interleukin-12; D007371:Interferon-gamma; D011070:Poly I-C
J Virol. 2008 Apr;82(7):3561-73
18234800
Blood. 2006 Mar 1;107(5):1963-9
16249391
Science. 2007 Jan 5;315(5808):107-11
17204652
Biomaterials. 2007 Feb;28(6):994-1004
17118442
Adv Drug Deliv Rev. 2005 Jan 10;57(3):475-82
15560953
J Med Virol. 2006 Jun;78(6):711-8
16628588
Eur J Immunol. 1999 Jan;29(1):196-202
9933101
Nature. 2006 Apr 6;440(7085):808-12
16489357
J Immunol. 2010 Jan 1;184(1):203-11
19949090
J Virol. 2001 May;75(9):4413-9
11287592
J Virol. 2001 Oct;75(19):8949-56
11533158
Angew Chem Int Ed Engl. 1998 Sep 4;37(16):2201-2205
29711461
Annu Rev Immunol. 2000;18:767-811
10837075
Adv Drug Deliv Rev. 2009 Mar 28;61(3):218-25
19168103
Eur J Immunol. 2007 Aug;37(8):2063-74
17628858
Vaccine. 2004 Jun 23;22(19):2406-12
15193402
Blood. 2006 Mar 1;107(5):1818-27
16263796
Immunology. 2006 Jan;117(1):78-88
16423043
Nat Med. 2004 Aug;10(8):806-10
15286782
Int J Pharm. 2009 Jan 5;365(1-2):61-8
18812217
J Exp Med. 1994 Jul 1;180(1):83-93
8006603
Langmuir. 2004 Apr 13;20(8):3398-406
15875874
Angew Chem Int Ed Engl. 2009;48(45):8485-9
19810070
J Immunol. 2003 Oct 15;171(8):4320-8
14530357
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15190-4
16219698
Vaccine. 2008 Sep 15;26(39):5046-57
18680779
Biomacromolecules. 2004 Sep-Oct;5(5):1962-72
15360312
J Immunol Methods. 2004 Apr;287(1-2):109-24
15099760
J Immunol. 1995 May 15;154(10):5071-9
7730613
J Control Release. 2006 May 15;112(2):175-85
16563545
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2574-9
18256187
Eur J Immunol. 1996 Mar;26(3):659-68
8605935
J Exp Med. 2008 Jan 21;205(1):7-12
18195078
Leukemia. 2002 Jul;16(7):1324-30
12094257
Vaccine. 1999 Mar 5;17(9-10):1047-56
10195614
Nat Med. 2003 Jul;9(7):867-73
12835707
AIDS Res Hum Retroviruses. 1998 May 1;14(7):551-60
9591709
Trends Immunol. 2007 Jan;28(1):19-25
17126600
J Infect Dis. 2005 May 15;191(10):1680-5
15838795
J Drug Target. 2009 Sep;17(8):652-61
19622019
Science. 1998 Nov 6;282(5391):1111-4
9804547